Outlook on the Clinical Trials Software Global Market to 2027 – Unified Clinical Trial Platforms for Next-Generation Clinical Trials Presents Opportunities

Research and Markets Logo

DUBLIN, Nov. 4, 2022 /PRNewswire/ — The “Clinical Trials Software Market – Global Outlook and Forecast 2022-2027” report has been added to  ResearchAndMarkets.com’s offering.


Clinical trials play an essential role in discovering new treatments for diseases and better ways to detect diseases, diagnose, and prevent the chance of developing the disease. The clinical trial process indicates what works for humans and what doesn’t by testing them on humans in a professional setup. The clinical trials software market growth is due to the increasing demand from pharmaceutical organizations to minimize the cost of medical research, reduce the burden, and increase access to advanced technologies.

Clinical trial software is also known as a clinical trial management system (CTMS). The software is used to manage research activities by the contract research organization (CROs). Increasing clinical trials worldwide drive the demand for new standard software solutions that enable easy access to activities for sponsors, CROs, medical device manufacturers, and outsourcing organizations engaged in medical research activities.

In global biopharmaceutical industries, there are significant changes addressed in the last decades, such as externalizing drugs research and development activities and manufacturing with the help of crucial strategies such as a partnership with small-medium size biopharma companies, academic institutes, government research institutes, and centers, etc. As a part of the significant changes in those industries, CROs became essential to clinical trial services. It helps speed up drug development processes and increase the manufacturing capabilities per the market’s needs. But the introduction of CTMS solved several challenges. It allowed the CROs and sponsors to overcome the restraint burden in clinical trials, from drug discovery to clinical trial phases and the approval cycle of drugs.

Recently, the COVID-19 crisis increased the digitalization of medical trials, and the adoption of digital tools and remote monitoring devices in the virtual clinical trial process has risen sharply. High focus on R&D activities, increasing demand for specialty medicines, and real-world evidence are some factors that led to the adoption of clinical trial management software solutions.

Remote clinical trial monitoring is the new standard for performing research in recent times. Clinical trials are a highly complex and expensive, and time-consuming process. So, with the increasing burden of medical research activities, most biopharma companies complete clinical trials with their in-house capabilities or by contract research organizations. So, vendors are adopting remote monitoring software due to the growing security purpose, well-established protocol, and ensuring that the research site conducts the clinical trials as per the protocol.

The COVID-19 pandemic has accelerated the ongoing shift toward remote monitoring through clinical trial management software solutions. It is one of the essential elements in the medical practice and is one of the most critical connections between CROs, sponsors, and the research site.

Cloud computing is a rapidly growing concept leveraging opportunities for market vendors. The shift from traditional methods such as paperwork to complete electronic tool applications will provide lucrative opportunities for market growth. The electronic data capture, transcribing data, Smart devices, and wearable solutions help directly collect data from patients without visiting the trial site. It helps collect data faster without disturbing patients’ daily life activities. It helps in the retention of patients. It reduced transportation and travel cost. Conversely, the growing craze for virtual research activities among the biopharma and medical device organizations will drive the demand for Clinical trials management software.



Due to insufficient recruitment and retention of participants in the study population, more than 80% of the research is failing, getting extended, and adding new study sites. Virtual clinical trials are witnessing growth due to increased patient enrolment through software solutions. In contrast, virtual patient recruitment software allows recruiting patients from across the globe, fulfills the demand, and increases the chances of success. It helps to eliminate the frequent traveling to study sites and do automation in medical data collection, increasing patient engagement, and retention.

Virtual collaboration strategies in medical research, using clinical trials management software, allow businesses to work rapidly and more efficiently, eliminate the need for document sharing to additional office locations, and reduce the burden.

Key players prefer the usage of unified platforms for conducting medical research. This provides multiple features that companies can use to conduct research. Medidata, a large clinical trials software provider, has one of the robust unified platforms most customers use.

As per the Clinical Trials Arena article 2022, IQVIA is one of the leading pharma companies in cloud computing. It shows that the filing of the companies in the pharmaceutical industry increased 12% between Q2 to Q3 in 2021.

One of the factors driving the market growth is the increasing complexity of clinical trial processes. Stringent regulation, the longer lifecycle of research, and high cost significantly increased the adoption of digital tools in tests to reduce the cost and timeline challenges.

During the pandemic COVID-19, most biopharma companies rapidly turned toward vaccine production. As well as running clinical trials were conducted using software solutions like remote monitoring and more.

Key Questions Answered:

1. What was the global clinical trials management software market value in 2021?

2. How big is the clinical trials management system market?

3. Who are the key vendors in the clinical trials management systems market?

4. What are the factors driving the clinical trials management software market growth?

Key Topics Covered:



1 Research Methodology



2 Research Objectives



3 Research Process



4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.1.3 Market Estimation Caveats

4.2 Base Year

4.3 Scope of the Study

4.3.1 Market Segmentation by Deployment

4.3.2 Market Segmentation by Delivery

4.3.3 Market Segmentation by Feature

4.3.4 Market Segmentation by End-User

4.3.5 Market Segmentation by Geography



5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation



6 Market at a Glance



7 Introduction

7.1 Overview

7.1.1 Demand for Advanced Software



8 Premium Insights

8.1 Overview



9 Market Opportunities & Trends

9.1 New Technologies in Clinical Trials

9.2 Increased Virtual Clinical Trials

9.3 Unified Clinical Trial Platforms for Next-Generation Clinical Trials



10 Market Growth Enablers

10.1 Cloud Computing in Clinical Trials

10.2 Advent of Drug Discovery Start-Ups & Small Biopharma Companies

10.3 Increased Expenditure & R&D by Biopharma Companies



11 Market Restraints

11.1 Stringent Regulatory Guidelines Related to Data Handling

11.2 Data Security Risks

11.3 Use of Traditional Clinical Trial Methods



12 Market Landscape

12.1 Market Overview

12.2 Market Size & Forecast

12.3 Five Forces Analysis

12.3.1 Threat of New Entrants

12.3.2 Bargaining Power of Suppliers

12.3.3 Bargaining Power of Buyers

12.3.4 Threat of Substitutes

12.3.5 Competitive Rivalry



13 Deployment

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 On-Enterprise

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.3.3 Market by Geography

13.4 On-Site

13.4.1 Market Overview

13.4.2 Market Size & Forecast

13.4.3 Market by Geography



14 Delivery

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Web-Based

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.3.3 Market by Geography

14.4 Saas

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.4.3 Market by Geography

14.5 On-Premise

14.5.1 Market Overview

14.5.2 Market Size & Forecast

14.5.3 Market by Geography



15 Feature

15.1 Market Snapshot & Growth Engine

15.2 Market Overview

15.3 Edc

15.3.1 Market Overview

15.3.2 Market Size & Forecast

15.3.3 Market by Geography

15.4 Ecoa & Epro

15.4.1 Market Overview

15.4.2 Market Size & Forecast

15.4.3 Market by Geography

15.5 Econsent

15.5.1 Market Overview

15.5.2 Market Size & Forecast

15.5.3 Market by Geography



16 End-User

16.1 Market Snapshot & Growth Engine

16.2 Market Overview

16.3 Cros

16.3.1 Market Overview

16.3.2 Market Size & Forecast

16.3.3 Market by Geography

16.4 Biotech & Pharmaceutical Companies

16.4.1 Market Overview

16.4.2 Market Size & Forecast

16.4.3 Market by Geography

16.5 Medical Device Manufacturers

16.5.1 Market Overview

16.5.2 Market Size & Forecast

16.5.3 Market by Geography

16.6 Others

16.6.1 Market Overview

16.6.2 Market Size & Forecast

16.6.3 Market by Geography



17 Geography



18 North America



19 Europe



20 APAC



21 Latin America



22 Middle East & Africa



23 Competitive Landscape

23.1 Competition Overview

23.2 Market Share Analysis

23.2.1 Bsi Business Systems Integration AG

23.2.2 Clario

23.2.3 Dassault Systemes

23.2.4 Iqvia

23.2.5 Labcorp Drug Development

23.2.6 Oracle Corporation

23.2.7 Parexel International Corporation



24 Key Company Profiles

24.1 Bsi Business Systems Integration AG

24.1.1 Business Overview

24.1.2 Product Offerings

24.1.3 Key Strategies

24.1.4 Key Strengths

24.1.5 Key Opportunities

24.2 Clario

24.2.1 Business Overview

24.2.2 Product Offerings

24.2.3 Key Strategies

24.2.4 Key Strengths

24.2.5 Key Opportunities

24.3 Dassault Systemes

24.3.1 Business Overview

24.3.2 Product Offerings

24.3.3 Key Strategies

24.3.4 Key Strengths

24.3.5 Key Opportunity

24.4 Iqvia

24.4.1 Business Overview

24.4.2 Product Offerings

24.4.3 Key Strategies

24.4.4 Key Strengths

24.4.5 Key Opportunities

24.5 Labcorp Drug Development

24.5.1 Business Overview

24.5.2 Product Offerings

24.5.3 Key Strategies

24.5.4 Key Strengths

24.5.5 Key Opportunities

24.6 Oracle Corporation

24.6.1 Business Overview

24.6.2 Product Offerings

24.6.3 Key Strategies

24.6.4 Key Strengths

24.6.5 Key Opportunities

24.7 Paraxel International Corporation

24.7.1 Business Overview

24.7.2 Product Offerings

24.7.3 Key Strategies

24.7.4 Key Strengths

24.7.5 Key Opportunities



25 Other Prominent Vendors

25.1 Advarra

25.1.1 Business Overview

25.1.2 Product Offerings

25.2 Arisglobal

25.2.1 Business Overview

25.2.2 Product Offerings

25.3 Astracore

25.3.1 Business Overview

25.3.2 Product Offerings

25.4 Axiom Real-Time Metrics

25.4.1 Business Overview

25.4.2 Product Offerings

25.5 Castor Edc

25.5.1 Business Overview

25.5.2 Product Offerings

25.6 Clincapture

25.6.1 Business Overview

25.6.2 Product Offerings

25.7 Datatrial

25.7.1 Business Overview

25.7.2 Product Offerings

25.8 Datatrak Int.

25.8.1 Business Overview

25.8.2 Product Offerings

25.9 Ibm

25.9.1 Business Overview

25.9.2 Product Offerings

25.10 Florence Healthcare

25.10.1 Business Overview

25.10.2 Product Offerings

25.11 Fortress Medical

25.11.1 Business Overview

25.11.2 Product Offerings

25.12 Medrio

25.12.1 Business Overview

25.12.2 Product Offerings

25.13 Openclinica, LLC

25.13.1 Business Overview

25.13.2 Product Offerings

25.14 Realtime Software Solutions

25.14.1 Business Overview

25.14.2 Product Offerings

25.15 Research Manager

25.15.1 Business Overview

25.15.2 Product Offerings

25.16 Reify Health, Inc.

25.16.1 Business Overview

25.16.2 Product Offerings

25.17 Signant Health

25.17.1 Business Overview

25.17.2 Product Offerings

25.18 Sofpromed

25.18.1 Business Overview

25.18.2 Product Offerings

25.19 Statsols

25.19.1 Business Overview

25.19.2 Product Offerings

25.20 Veeva Systems

25.20.1 Business Overview

25.20.2 Product Offerings



26 Report Summary



27 Quantitative Summary

28 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/ssyxdz

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[email protected]

 

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

 

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/outlook-on-the-clinical-trials-software-global-market-to-2027—unified-clinical-trial-platforms-for-next-generation-clinical-trials-presents-opportunities-301669169.html

SOURCE Research and Markets

Leave a Reply

Your email address will not be published. Required fields are marked *